Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma (review of technology appraisal guidance 37)
National Institute for Health and Clinical Excellence
Record ID 32011000402
English
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/nicemedia/live/11923/39618/39618.pdf
Year Published:
2008
URL for published report:
http://guidance.nice.org.uk/TA137
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Antibodies, Monoclonal, Murine-Derived
- Lymphoma, Non-Hodgkin
- Recurrence
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.